Episode 61
Biotech Hangout
00:00
The Impact of the Justice Department and SEC on Short Sellers on Biotech Stocks
Short selling biotech stocks has surged recently as tracked by shorting interest in the XBI. As of May 1st, 45 million shares or 56% of the XBI shares across 149 biotech companies were shorted. I think every public company that's waiting for data is wishing they were private so that they could actually negotiate without a stock price sitting there.
Transcript
Play full episode
